|
|
|
HR0153 |
|
LRB094 08374 CSA 38570 r |
|
|
1 |
| HOUSE RESOLUTION
|
2 |
| WHEREAS, Ovarian cancer is the seventh most common cancer |
3 |
| among women and the fifth leading cause of cancer death after |
4 |
| lung and bronchus, breast, colorectal, and pancreatic cancers; |
5 |
| ovarian cancer causes more deaths than any other cancer of the |
6 |
| female reproductive system; and
|
7 |
| WHEREAS, The American Cancer Society estimates that |
8 |
| approximately 22,220 new cases of ovarian cancer will be |
9 |
| diagnosed in the United States in 2005 and an estimated
16,000 |
10 |
| women died from ovarian cancer in the United States during |
11 |
| 2004; and
|
12 |
| WHEREAS, Ovarian cancer is the deadliest malignancy of the |
13 |
| female reproductive system, in part because only about 24 |
14 |
| percent of the cases are detected during the early stages of |
15 |
| the disease; and
|
16 |
| WHEREAS, An estimated 1,000 Illinois women die from ovarian |
17 |
| cancer annually; and
|
18 |
| WHEREAS, The Pap test, which is an effective detector of |
19 |
| early cervical cancer, detects ovarian cancer only in the later |
20 |
| stages; and
|
21 |
| WHEREAS, Screening with sonograms and blood tests of women |
22 |
| who are high risks for developing ovarian cancer, such as women |
23 |
| with family histories of ovarian cancer or breast cancer, would |
24 |
| help to save lives by early diagnosis and effective treatment; |
25 |
| and
|
26 |
| WHEREAS, Other life-saving programs include public |
27 |
| education campaigns, programs to alert doctors regarding early |
28 |
| symptoms, insurance coverage for screening high risk |
29 |
| populations, and increased research; therefore, be it
|